EC: H2020 project brings new rapid Corona diagnostic to market
The European Commission (EC) has announced that one of the first 18 research and innovation projects funded by the EU to tackle the coronavirus is already delivering results. Researchers involved in the “HG nCoV19 test” project selected under the special Horizon 2020 call launched in January, have obtained approval to put a new rapid point-of-care diagnostic for COVID-19 on the market.
Bringing together public and private organisations from Ireland, Italy, the United Kingdom and China, the “HG nCoV19 test” project developed a new portable diagnostic system to detect viral infection that gives accurate and reliable results in 30 minutes. Today, HiberGene, the Irish company coordinating the project, announced that it had obtained the CE marking required for medical devices to be put on the market. The total EU contribution to the project is €930.000.
The HG nCoV19 test uses a low-complexity sample preparation method and can give results for samples with high to moderate viral loads, enabling rapid diagnosis of the disease at the early and highly infectious stage of infection. The project will continue to evaluate potential additional uses of the test, such as compatibility with new specimen types and patient cohorts.
For more information: